Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 13c

November 8, 2012 7:18 AM EST
Get Alerts CRTX Hot Sheet
Trade CRTX Now!
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 EPS of $0.19, $0.13 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $37.5 million versus the consensus estimate of $32 million.

For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment